KRASG12C mutation in metastatic colorectal cancer: a new target

被引：1
|
作者：
Ibrahim, Rebecca [1 ]
Saleh, Khalil [1 ]
Chahine, Claude [1 ]
Khoury, Rita [1 ]
Khalife, Nadine [2 ]
Lecesne, Axel [1 ]
机构：
[1] Gustave Roussy Canc Campus, Int Dept, F-94800 Villejuif, France
[2] Gustave Roussy Canc Campus, Dept Head & Neck Oncol, F-94800 Villejuif, France
来源：
FUTURE ONCOLOGY | 2023年 / 19卷 / 24期
关键词：
adagrasib; colorectal cancer; KRAS(G12C) mutation; RAS; sotorasib; INHIBITORS; SOTORASIB;
D O I：
10.2217/fon-2023-0223
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1641 / 1643
页数：3
相关论文
共 50 条
  • [31] Cost-effectiveness of sotorasib as a second-line treatment for non-small cell lung cancer with KRASG12C mutation in China and the United States
    Zhu, Ya-Ning
    Tang, Meng
    Sun, Ke-Xin
    Gao, Bei
    Shi, Xian-Peng
    Zhang, Peng
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [32] Efficacy and toxicity of KRASG12C inhibitors in advanced solid tumors: a meta-analysis
    Dang, Shoutao
    Zhang, Shuyang
    Zhao, Jingyang
    Li, Wei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [33] Aurora A Kinase Inhibition with VIC-1911Potentiates KRASG12C Inhibitor and Overcomes Resistance to Sotorasib in Lung Cancer
    Lee, J. W.
    Kim, S.
    Cruz-Gomez, S.
    Yang, C.
    Burtness, B.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S48 - S48
  • [34] The reactivity-driven biochemical mechanism of covalent KRASG12C inhibitors
    Hansen, Rasmus
    Peters, Uif
    Babbar, Anjali
    Chen, Yuching
    Feng, Jun
    Janes, Matthew R.
    Li, Lian-Sheng
    Ren, Pingda
    Liu, Yi
    Zarrinkar, Patrick P.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2018, 25 (06) : 454 - +
  • [35] Targeted Degradation of Oncogenic KRASG12C by VHL-Recruiting PROTACs
    Bond, Michael J.
    Chu, Ling
    Nalawansha, Dhanusha A.
    Li, Ke
    Crews, Craig M.
    ACS CENTRAL SCIENCE, 2020, 6 (08) : 1367 - 1375
  • [36] Mechanistic insights into the clinical Y96D mutation with acquired resistance to AMG510 in the KRASG12C
    Zhuang, Haiming
    Fan, Jigang
    Li, Mingyu
    Zhang, Hao
    Yang, Xiuyan
    Lin, Ligen
    Lu, Shaoyong
    Wang, Qing
    Liu, Yaqin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRASG12C
    Mortier, Jeremie
    Friberg, Anders
    Badock, Volker
    Moosmayer, Dieter
    Schroeder, Jens
    Steigemann, Patrick
    Siegel, Franziska
    Gradl, Stefan
    Bauser, Marcus
    Hillig, Roman C.
    Briem, Hans
    Eis, Knut
    Bader, Benjamin
    Nguyen, Duy
    Christ, Clara D.
    CHEMMEDCHEM, 2020, 15 (10) : 827 - 832
  • [38] Validation of an LC-MS/MS method for the determination of sotorasib, a KRASG12C inhibitor, in human plasma
    Wong, Philip
    Akrami, Anna
    Houk, Brett
    Vuu, Irene
    James, Christopher A.
    BIOANALYSIS, 2022, 14 (19) : 1281 - 1292
  • [39] Population Pharmacokinetics of Sotorasib in Healthy Subjects and Advanced Solid Tumor Patients Harboring a KRASG12C Mutation from Phase 1 and Phase 2 Studies
    Nagase, Mario
    Houk, Brett
    Vuu, Irene
    Cardona, Panli
    Dutta, Sandeep
    Lin, Chih-Wei
    AAPS JOURNAL, 2025, 27 (01):
  • [40] Covalent fragment mapping of KRasG12C revealed novel chemotypes with in vivo potency
    Orgovan, Zoltan
    Peczka, Nikolett
    Petri, Laszlo
    Abranyi-Balogh, Peter
    Randelovic, Ivan
    Toth, Szilard
    Szakacs, Gergely
    Nyiri, Kinga
    Vertessy, Beata
    Palfy, Gyula
    Vida, Istvan
    Perczel, Andras
    Tovari, Jozsef
    Keseru, Gyorgy M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 250
12345